$AKTX

$7.63 -$0.59 (7.23%) Close

$AKTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.57B shares outstanding

Who owns AKTX?

By type of holder

Institutions 0.0% Insiders 0.0% Everyone else 100.0%

Concentration Top 10 holders own 396.4%

Samir R. Patel 212.8% · Ray Prudo, M.D. 183.6%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

+3 vs last qtr

Net shares bought

+83.1K

by institutions in Q2 2026

New / sold out

5 / 2

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

MMCAP International Inc. SPC NEW +100.0K
Jane Street Group, LLC NEW +15.5K

Biggest sellers in Q2 2026

Armistice Capital, LLC SOLD OUT −38.9K
IFP Advisors, Inc −7.3K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Akari Therapeutics PLC in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+181.8%

+181.85% a year

Each share's claim on the business

−64.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $5.14M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years14% Under 1 year86%

Quarterly turnover

131.1%

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting AKTX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MI MMCAP International Inc. SPC	100.0K	0.00%	NEW	Q2 '26	0.1%
Shares held by quarter Peak holding100.0K (Q2'26) Change over 8 quarters+100.0K Share of the company0.000% MMCAP International Inc. SPC's full portfolio →
AC Armistice Capital, LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding2.7M (Q4'25) Change over 8 quarters0 Armistice Capital, LLC's full portfolio →

MMCAP International Inc. SPC

100.0K

% of company

0.00%

Change vs last qtr

NEW

Held since

Q2 '26

Armistice Capital, LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

9 more super investors behind a free account

See every manager holding Akari Therapeutics PLC, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting AKTX on Form N-PORT; together they hold 0.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
RC RiverNorth Capital and Income Fund RiverNorth Capital and Income Fund	$319	1.1K	0.00%	0.00%	December 31, 2025
RO RiverNorth Opportunities Fund Inc. Rivernorth Opportunities Fund Inc.	$147	509	0.00%	0.00%	December 31, 2025

RiverNorth Capital and Income Fund

Position value

$319

% of company

0.00%

% of the fund

0.00%

As of

December 31, 2025

RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc.

Position value

$147

% of company

0.00%

% of the fund

0.00%

As of

December 31, 2025

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SR Samir R. Patel 5%+ holder 13D · 10.4%	9.73B	212.79%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company212.790% Disclosed stake13D · 10.4% View the 13D/G filing →
RP Ray Prudo, M.D. 5%+ holder 13D · 8.9%	8.39B	183.60%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company183.600% Disclosed stake13D · 8.9% View the 13D/G filing →

Samir R. Patel

5%+ holder13D · 10.4%

9.73B

% of company

212.79%

Change vs last qtr

—

Held since

—

Ray Prudo, M.D.

5%+ holder13D · 8.9%

8.39B

% of company

183.60%

Change vs last qtr

—

Held since

—

Comments